BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9676323)

  • 1. Intermittent claudication. Conservative treatment, endovascular repair or open surgery for femoropopliteal disease.
    Jensen LP
    Ann Chir Gynaecol; 1998; 87(2):137-40. PubMed ID: 9676323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser atherectomy for lower extremity revascularization: An adjunctive endovascular treatment option.
    Zhou W; Bush RL; Lin PH; Peden EK; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):268-74. PubMed ID: 16959719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subintimal angioplasty as a treatment of femoropopliteal artery occlusions.
    Laxdal E; Jenssen GL; Pedersen G; Aune S
    Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):578-82. PubMed ID: 12787703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery.
    Laxdal E; Eide GE; Wirsching J; Jenssen GL; Jonung T; Pedersen G; Amundsen SR; Dregelid E; Aune S
    Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):410-7. PubMed ID: 15350565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrapopliteal intervention for the treatment of the claudicant.
    Menard MT; Belkin M
    Semin Vasc Surg; 2007 Mar; 20(1):42-53. PubMed ID: 17386363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Popliteal artery aneurysms. Factors associated with thromboembolism and graft failure.
    Martelli E; Ippoliti A; Ventoruzzo G; De Vivo G; Ascoli Marchetti A; Pistolese GR
    Int Angiol; 2004 Mar; 23(1):54-65. PubMed ID: 15156131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of comorbidity on long-term results of above-knee prosthetic femoropopliteal bypass for intermittent claudication.
    Pedersen G; Laxdal E; Hagala M; Aune S
    Int Angiol; 2005 Sep; 24(3):245-9. PubMed ID: 16158033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote endarterectomy: first choice in surgical treatment of long segmental SFA occlusive disease?
    Smeets L; Ho GH; Hagenaars T; van den Berg JC; Teijink JA; Moll FL
    Eur J Vasc Endovasc Surg; 2003 Jun; 25(6):583-9. PubMed ID: 12787704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transluminal angioplasty of infrarenal arteries in intermittent claudication.
    Henriksen LO; Jørgensen B; Holstein PE; Tønnesen KH; Karle A; Sager P
    Acta Chir Scand; 1988 Oct; 154(10):573-6. PubMed ID: 2975133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early results of retrograde transpopliteal angioplasty of iliofemoral lesions.
    Saha S; Gibson M; Magee TR; Galland RB; Torrie EP
    Cardiovasc Intervent Radiol; 2001; 24(6):378-82. PubMed ID: 11907743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK; Geroulakos G; Nicolaides AN
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Nylaende M; Abdelnoor M; Stranden E; Morken B; Sandbaek G; Risum Ø; Jørgensen JJ; Lindahl AK; Arnesen H; Seljeflot I; Kroese AJ
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):3-12. PubMed ID: 17055756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: acute and one-year results.
    Krankenberg H; Sorge I; Zeller T; Tübler T
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):12-7. PubMed ID: 15619276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
    Commeau P; Barragan P; Roquebert PO
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can endovascular therapy of infrainguinal disease for claudication be justified?
    Keefer A; Davies MG; Illig KA
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):229-37. PubMed ID: 15151471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of intermittent claudication.
    King RB
    Aust Fam Physician; 1979 Jul; 8(7):719-30. PubMed ID: 485960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment methods for long occlusions of the femoropopliteal segment in patients with intermittent claudication: Minireview.
    Fialova J; Utikal P; Bachleda P; Kocher M; Cerna M; Vomackova K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):203-7. PubMed ID: 23549509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent claudication caused by atherosclerosis in patients aged forty years and younger.
    Valentine RJ; MacGillivray DC; DeNobile JW; Snyder DA; Rich NM
    Surgery; 1990 May; 107(5):560-5. PubMed ID: 2139746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoropopliteal bypass grafting for intermittent claudication: is pessimism warranted?
    Donaldson MC; Mannick JA
    Arch Surg; 1980 Jun; 115(6):724-7. PubMed ID: 7387359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.